Suchergebnisse - "Quinn, Ryann"

PubPharm (9)

1

Efficacy and longevity of immune response to 3^rd COVID-19 vaccine and effectiveness of a 4^th dose in severely immunocompromised patients with cancer

enthalten in: bioRxiv.org | 2024

von Thakkar, A. | Pradhan, K. | Duva, B. | +20

2

Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma

enthalten in: Clinical hematology international | 2023

von Bazarbachi, A. | Reef, D. | Narvel, H. | +38

3

Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer : A single arm clinical trial

enthalten in: eLife | 2023

von Thakkar, A. | Pradhan, K. | Duva, B. | +20

4

Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma

enthalten in: Clinical hematology international | 2023

von Bazarbachi, A. | Reef, D. | Narvel, H. | +38

5

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines : a retrospective observational study from the COVID-19 and Cancer Consortium

enthalten in: Lancet regional health. Americas | 2023

von Choueiri, T. | Labaki, C. | Bakouny, Z. | +42

6

Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave

enthalten in: Cancer cell | 2022

von Lee, M. | Quinn, R. | Pradhan, K. | +17

7

Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer

enthalten in: Cancer cell | 2022

von Shapiro, L. | Thakkar, A. | Campbell, S. | +21

8

Impact of Precision Medicine on Clinical Outcomes : A Single-Institution Retrospective Study

enthalten in: Frontiers in oncology | 2021

von Quinn, R. | Patel, R. | Sison, C. | +2

9

Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma

enthalten in: Leukemia & lymphoma | 2014

von Mark, T. | Bowman, I. | Rossi, A. | +11

1
[1]